News Releases Year: - Any -20192018201720162015201420132012 Items per page 102550 04/22/15 Summary ToggleClearside Biomedical, Inc. Announces Purchase of iScience Patent Portfolio for Suprachoroidal Space Drug Delivery Releasec1212de7-165d-4726-a5c3-2665b8dbbc61_2139308.pdf 7.7 KB 03/16/15 Summary ToggleClearside Biomedical, Inc. Reports Efficacy and Safety Results in Non-infectious Uveitis Using a Single Suprachoroidal Injection of Triamcinolone Acetonide Release7f345fca-7698-4c2e-9790-d019fd384ea3_2139310.pdf 14.1 KB 03/02/15 Summary ToggleClearside Biomedical, Inc. Initiates Phase 2 Clinical Trial to Evaluate Reducing Treatment Visits While Improving Outcomes in Macular Edema Associated with Retinal Vein Occlusion Release3869c5b0-b0e9-4a9a-bfad-0171d22fffca_2139294.pdf 12.2 KB 01/05/15 Summary ToggleClearside Biomedical, Inc. Initiates Phase 2 Clinical Trial for the Treatment of Macular Edema Associated with Non-Infectious Uveitis Release8d62abdc-64a2-4980-9ec4-380a6c10fdbf_2139305.pdf 10 KB 10/15/14 Summary ToggleClearside Biomedical, Inc. Announces Ongoing Results in Phase 1/2 Clinical Trial in Patients with Non-infectious Uveitis Releasead0092d2-1af4-4032-bce2-5953a84c3d7c_1980587.pdf 10.2 KB 09/04/14 Summary ToggleClearside Biomedical, Inc. Announces Fourth Patent Allowance in the U.S. Related to Proprietary Microneedle Drug Delivery Methods and Devices Release683a3000-b106-4a80-acf5-0405ce207c1c_1981119.pdf 7.2 KB 09/02/14 Summary ToggleClearside Biomedical, Inc. Completes $16 Million Series B Financing Releasee7047d18-254e-4b56-9962-2892b5445b6e_1981123.pdf 6.5 KB 01/29/14 Summary ToggleClearside Biomedical to Present Research on Proprietary Retinal Therapeutics Platform at 2014 ARVO Meeting Release2b6d047a-9f91-4603-9c98-6681bf215ef2_1981128.pdf 7.8 KB 01/29/14 Summary ToggleClearside Biomedical, Inc. Announces Third Patent Allowance in the U.S. Related to Proprietary Microneedle Drug Delivery Methods and Devices Releasee5b98b27-ff50-4eb0-883b-6337b951b806_1981127.pdf 7.8 KB 08/05/13 Summary ToggleClearside Biomedical, Inc. Names Glenn Noronha, Ph.D., Executive Vice President, Research and Development Release8e433345-4b89-4a89-8336-d9385784921e_1981129.pdf 10.5 KB Pagination First page First Previous page Page 9 Page 10 Current page 11 Page 12 Next page Last page Last
